The blood–brain barrier (BBB) is a structural and biochemical feature of the cerebral vasculature. Unlike capillaries elsewhere in the body, those supplying the brain are lined by endothelial cells joined by tight junctions , protein complexes that close the gaps between adjacent cells. Astrocyte end-feet and pericytes wrap around these capillaries, contributing to the barrier's selectivity and maintenance. The result is a controlled interface that permits the passage of small lipid-soluble molecules, oxygen, and carbon dioxide, whilst sharply restricting larger molecules, most pathogens, and many pharmacological compounds.
Physiologically, the BBB maintains the precise ionic and neurochemical environment that neuronal signalling requires. Glucose and certain amino acids are actively transported across via specialised carrier proteins; most water-soluble drugs, by contrast, cross poorly or not at all. This selectivity is the central pharmacokinetic challenge for any compound intended to act within the central nervous system, including cannabinoids, neuropeptides, and investigational psychedelic compounds under research scrutiny.
In the context of plant-based medicine and cannabinoid research, the lipophilic character of compounds such as THC allows passive diffusion across the BBB, whilst more polar or larger molecules face significant transport limitations. Researchers studying neuropeptides and psychedelic substances often assess BBB permeability as an early pharmacokinetic variable, since CNS activity is contingent on crossing this barrier. Permeability is typically estimated using partition coefficient modelling, in vitro cell-culture assays, or in vivo imaging studies; no single method is considered definitive.
The BBB is not uniformly impermeable across all brain regions. Circumventricular organs , small zones such as the area postrema , lack tight junctions and permit greater molecular exchange, a distinction relevant to nausea-related pharmacology and certain peptide signalling pathways. Pathological states including inflammation and traumatic injury can transiently compromise BBB integrity, a variable that complicates interpretation of clinical research findings.
Sources: